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Assessment of tissue health is the Holy Grail in determining
whether patients are in shock and when resuscitation efforts
can be stopped because recovery has occurred. Tissue health,
itself, results from the complex interaction between cardiac
pump function, circulating blood volume and vasomotor tone,
the number of capillary units perfused, and the ability of the
tissue to use the delivered oxygen. Although the macro-
circulation seems well evaluated both invasively and non-
invasively using measures of blood pressure, cardiac output
and mixed venous oxygen saturation, some studies suggest
that resuscitation aiming only towards macrocirculatory
parameters might be insufficient to improve tissue perfusion.
Presently, there are neither generally accepted measures of
global tissue viability nor reasonable leading candidate
measures on the horizon. For example, although the strong
ion gap assessment of metabolic acidosis predicts mortality
in trauma patients, it cannot be used to assess response to
therapy because crystalloid resuscitation itself alters the
strong ion gap [1]. Furthermore, although regional measures
of metabolism such as the sublingual tissue partial pressure
of carbon dioxide [2] and urethral mucosal NAD/NADH ratios
[3] track circulatory deficiency and resuscitation, their ability
to assess the global status and their intrinsically highly
unstable baseline values make their routine clinical use
limited.
Non-invasive continuous measurements of tissue hemoglobin
oxygenation using near-infrared spectroscopy have been
studied and proposed to assess tissue hypoperfusion. The
absolute tissue oxygen saturation (StO2) has been proven to
be instrumental in predicting outcome in trauma patients [4]
but is otherwise relatively insensitive to define earlier stages
of tissue hypoperfusion, despite adequate macrocirculation
resuscitation aiming to prevent ischemic organ injury. The use
of continuous StO2 as a marker of tissue perfusion is still
being studied, however, and potentially may demonstrate
greater sensitivity early on in trauma resuscitation.
Increased interest in functional hemodynamic monitoring [5],
for which the fluid challenge or exercise stress test are
classic examples, has recently been applied since observed
static numbers cannot really evaluate the adequacy of tissue
perfusion, especially regional measures of blood flow and
tissue viability. Although systemic hypotension with hypo-
perfusion, a low mixed venous oxygen saturation and elevated
serum lactate levels may be used to identify tissue ischemia,
normal blood pressure, flow rates, mixed venous oxygen
saturation and lactate levels do not ensure the adequacy of
resuscitation. In this regard, the use of a transient vascular
occlusion test (VOT) to assess StO2 responses has gained
increasing interest.
The use of an ischemic challenge, or VOT, has further
improved and expanded its predictive ability to scenarios
such as trauma, severe sepsis and septic shock [6-8]. The
VOT is a provocative test in which StO2 is measured on a
distal site, such as the thenar eminence, whilst a transient
rapid vascular occlusion is performed, using a sphygmo-
manometer, for either a defined time interval (for example,
3 minutes) or until the StO2 decreases to a defined minimal
threshold. Following this, the vascular occlusion is released
and the StO2 is allowed to recover. Several emergent
parameters arise from this technique, including the rate of
deoxygenation (thought to reflect the local metabolic rate),
the rate of reoxygenation (thought to reflect local cardio-
vascular reserve and microcirculatory flow), and the
postobstructive hyperemic response. The VOT has not been
standardized, however, and has to be better characterized
before making a decision on its relevance.
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Specifically, StO2 can be measured at different anatomical
sites (thenar, forearm, deltoid), using different near-infrared
spectroscopy probe sizes (15 mm vs. 25 mm) and different
types and levels of ischemic deflation thresholds or ischemic
times. Information is reported in the present issue on
methodological issues such as depth for measurement,
different modes of VOT, and determinants of VOT
abnormalities. Finally, the StO2 behavior in different disease
states and forms of resuscitation and the associate VOT
parameters have not been defined. Given the non-invasive
and potentially automated nature of StO2 and the VOT,
respectively, if these measures are proven useful in clinical
decision-making, then their impact on overall resuscitation
management would be great.
The present supplement to Critical Care aims to address
several aspects of these issues, from defining the basic
physics of near-infrared spectroscopy and the VOT to clinical
studies further exploring the potential of this technique in
different patient groups. As with all new technologies applied
to the clinical sphere, it is mandatory to identify their operat-
ing characteristics and limitations before extending their
measures to patient care. Following that, it is always useful to
remember that no monitoring device – no matter how
insightful its data – will improve patient outcome unless
coupled with a treatment that improves outcome.
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